English | Español

Technology/Innovation
+ Technology/Innovation
Gene Johnson | Mar 5, 2017

Analytics firm finds significant differences in MS treatment preferences
+ Technology/Innovation
Gene Johnson | Mar 5, 2017

Testosterone therapy trials in older men draw mixed results
+ Regulatory
Gene Johnson | Mar 5, 2017

Respiratory virus vaccine enters clinical testing phase
+ Technology/Innovation
Gene Johnson | Mar 5, 2017

Psychiatric hospitalization may lead to increased stroke risk
+ Regulatory
Gene Johnson | Mar 5, 2017

Stroke Association says life-saving treatment often eludes minorities
+ Technology/Innovation
Gene Johnson | Mar 5, 2017

Estrogen therapy reduces gum disease in postmenopausal women
+ Technology/Innovation
Gene Johnson | Mar 5, 2017

Patient navigators make a difference in cancer patients' treatment
+ Community
Gene Johnson | Mar 5, 2017

Shire honors Rare Disease Day with launch of 'Rare Count'

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones